Literature DB >> 26605301

HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCC.

Fabian Lohaus1, Annett Linge1, Michael Baumann1.   

Abstract

Entities:  

Year:  2015        PMID： 26605301      PMCID： PMC4620098          DOI： 10.3978/j.issn.2305-5839.2015.09.35

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  6 in total

1.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

Authors:  Jay S Cooper; Thomas F Pajak; Arlene A Forastiere; John Jacobs; Bruce H Campbell; Scott B Saxman; Julie A Kish; Harold E Kim; Anthony J Cmelak; Marvin Rotman; Mitchell Machtay; John F Ensley; K S Clifford Chao; Christopher J Schultz; Nancy Lee; Karen K Fu
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

2.  Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

Authors:  Jacques Bernier; Christian Domenge; Mahmut Ozsahin; Katarzyna Matuszewska; Jean-Louis Lefèbvre; Richard H Greiner; Jordi Giralt; Philippe Maingon; Frédéric Rolland; Michel Bolla; Francesco Cognetti; Jean Bourhis; Anne Kirkpatrick; Martine van Glabbeke
Journal:  N Engl J Med       Date:  2004-05-06       Impact factor: 91.245

3.  CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).

Authors:  Panagiotis Balermpas; Franz Rödel; Claus Rödel; Mechthild Krause; Annett Linge; Fabian Lohaus; Michael Baumann; Inge Tinhofer; Volker Budach; Eleni Gkika; Martin Stuschke; Melanie Avlar; Anca-Lidia Grosu; Amir Abdollahi; Jürgen Debus; Christine Bayer; Stefan Stangl; Claus Belka; Steffi Pigorsch; Gabriele Multhoff; Stephanie E Combs; David Mönnich; Daniel Zips; Emmanouil Fokas
Journal:  Int J Cancer       Date:  2015-07-30       Impact factor: 7.396

4.  p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.

Authors:  Christine H Chung; Qiang Zhang; Christina S Kong; Jonathan Harris; Elana J Fertig; Paul M Harari; Dian Wang; Kevin P Redmond; George Shenouda; Andy Trotti; David Raben; Maura L Gillison; Richard C Jordan; Quynh-Thu Le
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

5.  The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.

Authors:  Randall J Kimple; Paul M Harari
Journal:  Ann Transl Med       Date:  2015-05

6.  HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Authors:  Fabian Lohaus; Annett Linge; Inge Tinhofer; Volker Budach; Eleni Gkika; Martin Stuschke; Panagiotis Balermpas; Claus Rödel; Melanie Avlar; Anca-Ligia Grosu; Amir Abdollahi; Jürgen Debus; Christine Bayer; Claus Belka; Steffi Pigorsch; Stephanie E Combs; David Mönnich; Daniel Zips; Cläre von Neubeck; Gustavo B Baretton; Steffen Löck; Howard D Thames; Mechthild Krause; Michael Baumann
Journal:  Radiother Oncol       Date:  2014-12-02       Impact factor: 6.280
  6 in total
  2 in total

1.  Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.

Authors:  Ayşe Sedef Köseer; Liliana R Loureiro; Justyna Jureczek; Nicola Mitwasi; Karla Elizabeth González Soto; Julia Aepler; Tabea Bartsch; Anja Feldmann; Leoni A Kunz-Schughart; Annett Linge; Mechthild Krause; Michael Bachmann; Claudia Arndt; Anna Dubrovska
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

Review 2.  Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications.

Authors:  Claudia Peitzsch; Jacqueline Nathansen; Sebastian I Schniewind; Franziska Schwarz; Anna Dubrovska
Journal:  Cancers (Basel)       Date:  2019-05-02       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.